A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome.

KMT2D Kabuki syndrome histone 3 lysine 4 methyltransferase intrinsically disordered region multiple congenital anomaly

Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
05 2020
Historique:
received: 30 10 2019
accepted: 24 12 2019
pubmed: 18 1 2020
medline: 28 4 2021
entrez: 18 1 2020
Statut: ppublish

Résumé

To investigate if specific exon 38 or 39 KMT2D missense variants (MVs) cause a condition distinct from Kabuki syndrome type 1 (KS1). Multiple individuals, with MVs in exons 38 or 39 of KMT2D that encode a highly conserved region of 54 amino acids flanked by Val3527 and Lys3583, were identified and phenotyped. Functional tests were performed to study their pathogenicity and understand the disease mechanism. The consistent clinical features of the affected individuals, from seven unrelated families, included choanal atresia, athelia or hypoplastic nipples, branchial sinus abnormalities, neck pits, lacrimal duct anomalies, hearing loss, external ear malformations, and thyroid abnormalities. None of the individuals had intellectual disability. The frequency of clinical features, objective software-based facial analysis metrics, and genome-wide peripheral blood DNA methylation patterns in these patients were significantly different from that of KS1. Circular dichroism spectroscopy indicated that these MVs perturb KMT2D secondary structure through an increased disordered to ɑ-helical transition. KMT2D MVs located in a specific region spanning exons 38 and 39 and affecting highly conserved residues cause a novel multiple malformations syndrome distinct from KS1. Unlike KMT2D haploinsufficiency in KS1, these MVs likely result in disease through a dominant negative mechanism.

Identifiants

pubmed: 31949313
doi: 10.1038/s41436-019-0743-3
pii: S1098-3600(21)00856-X
pmc: PMC7200597
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

867-877

Subventions

Organisme : Wellcome Trust
ID : 062164/Z/00/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/13/32/30069
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 213312/Z/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K011154/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102627/Z/13/Z
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Reijnders MRF, Ansor NM, Kousi M, et al. RAC1 missense mutations in developmental disorders with diverse phenotypes. Am J Hum Genet. 2017;101:466–477.
doi: 10.1016/j.ajhg.2017.08.007
Faundes V, Newman WG, Bernardini L, et al. Histone lysine methylases and demethylases in the landscape of human developmental disorders. Am J Hum Genet. 2018;102:175–187.
doi: 10.1016/j.ajhg.2017.11.013
Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem. 2012;81:65–95.
doi: 10.1146/annurev-biochem-051710-134100
Staby L, O’Shea C, Willemoes M, Theisen F, Kragelund BB, Skriver K. Eukaryotic transcription factors: paradigms of protein intrinsic disorder. Biochem J. 2017;474:2509–2532.
doi: 10.1042/BCJ20160631
Ng SB, Bigham AW, Buckingham KJ, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. 2010;42:790–793.
doi: 10.1038/ng.646
Faundes V, Malone G, Newman WG, Banka S. A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population. J Hum Genet. 2019;64:161–170.
doi: 10.1038/s10038-018-0536-6
Banka S, Howard E, Bunstone S, et al. MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome. Clin Genet. 2013;83:467–471.
doi: 10.1111/j.1399-0004.2012.01955.x
Adam MP, Banka S, Bjornsson HT, et al. Kabuki syndrome: international consensus diagnostic criteria. J Med Genet. 2019;56:89–95.
doi: 10.1136/jmedgenet-2018-105625
Banka S, Veeramachaneni R, Reardon W, et al. How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum. Eur J Hum Genet. 2012;20:381–388.
doi: 10.1038/ejhg.2011.220
Gurovich Y, Hanani Y, Bar O, et al. Identifying facial phenotypes of genetic disorders using deep learning. Nat Med. 2019;25:60–64.
doi: 10.1038/s41591-018-0279-0
Alisch RS, Barwick BG, Chopra P, et al. Age-associated DNA methylation in pediatric populations. Genome Res. 2012;22:623–632.
doi: 10.1101/gr.125187.111
Hannum G, Guinney J, Zhao L, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49:359–367.
doi: 10.1016/j.molcel.2012.10.016
Perez RF, Santamarina P, Tejedor JR, et al. Longitudinal genome-wide DNA methylation analysis uncovers persistent early-life DNA methylation changes. J Transl Med. 2019;17:15.
doi: 10.1186/s12967-018-1751-9
Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics. 2015;16:169.
doi: 10.1186/s12859-015-0611-3
Jaffe AE, Murakami P, Lee H, et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol. 2012;41:200–209.
doi: 10.1093/ije/dyr238
Morris TJ, Butcher LM, Feber A, et al. ChAMP: 450k Chip Analysis Methylation Pipeline. Bioinformatics. 2014;30:428–430.
doi: 10.1093/bioinformatics/btt684
Cocciadiferro D, Augello B, De Nittis P, et al. Dissecting KMT2D missense mutations in Kabuki syndrome patients. Hum Mol Genet. 2018;27:3651–3668.
doi: 10.1093/hmg/ddy241
Thomas M, Lu JJ, Ge Q, Zhang C, Chen J, Klibanov AM. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci USA. 2005;102:5679–5684.
doi: 10.1073/pnas.0502067102
Bjornsson HT, Benjamin JS, Zhang L, et al. Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med. 2014;6:256ra135.
doi: 10.1126/scitranslmed.3009278
Delorenzi M, Speed T. An HMM model for coiled-coil domains and a comparison with PSSM-based predictions. Bioinformatics. 2002;18:617–625.
doi: 10.1093/bioinformatics/18.4.617
Wolf E, Kim PS, Berger B. MultiCoil: a program for predicting two- and three-stranded coiled coils. Protein Sci. 1997;6:1179–1189.
doi: 10.1002/pro.5560060606
Berrow NS, Alderton D, Sainsbury S, et al. A versatile ligation-independent cloning method suitable for high-throughput expression screening applications. Nucleic Acids Res. 2007;35:e45.
doi: 10.1093/nar/gkm047
Whitmore L, Wallace BA. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 2004;32(Web Server issue):W668–W673.
doi: 10.1093/nar/gkh371
Gazali et al. Clinical Dysmorphology 2002. https://journals.lww.com/clindysmorphol/Fulltext/2002/04000/An_autosomal_recessive_syndrome_of_choanal.1.aspx .
Smigielski EM, Sirotkin K, Ward M, Sherry ST. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 2000;28:352–355
Landrum MJ, Lee JM, Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D1067.
doi: 10.1093/nar/gkx1153
Forbes SA, Beare D, Boutselakis H, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2017;45(D1):D777–D783.
doi: 10.1093/nar/gkw1121
Butcher DT, Cytrynbaum C, Turinsky AL, et al. CHARGE and Kabuki syndromes: gene-specific DNA methylation signatures identify epigenetic mechanisms linking these clinically overlapping conditions. Am J Hum Genet. 2017;100:773–788.
doi: 10.1016/j.ajhg.2017.04.004
Badalato L, Farhan SM, Dilliott AA, et al. KMT2D p.Gln3575His segregating in a family with autosomal dominant choanal atresia strengthens the Kabuki/CHARGE connection. Am J Med Genet A. 2017;173:183–189.
doi: 10.1002/ajmg.a.38010
Trider CL, Arra-Robar A, van Ravenswaaij-Arts C, Blake K. Developing a CHARGE syndrome checklist: health supervision across the lifespan (from head to toe). Am J Med Genet A. 2017;173:684–691.
doi: 10.1002/ajmg.a.38085
Schulz Y, Freese L, Manz J, et al. CHARGE and Kabuki syndromes: a phenotypic and molecular link. Hum Mol Genet. 2014;23:4396–4405.
doi: 10.1093/hmg/ddu156
Sakata S, Okada S, Aoyama K, et al. Individual clinically diagnosed with CHARGE syndrome but with a mutation in KMT2D, a gene associated with Kabuki syndrome: a case report. Front Genet. 2017;8:210.
doi: 10.3389/fgene.2017.00210
Glustein JZ, Weill M, Steinberg A. Anomalies of the nipple: an additional finding in CHARGE syndrome. Am J Med Genet. 1996;61:201.
doi: 10.1002/(SICI)1096-8628(19960122)61:3<201::AID-AJMG1>3.0.CO;2-X
Foulds N, Walpole I, Elmslie F, Mansour S. Carbimazole embryopathy: an emerging phenotype. Am J Med Genet A. 2005;132A:130–135.
doi: 10.1002/ajmg.a.30418
Hisama FM, Reyes-Mugica M, Wargowski DS, Thompson KJ, Mahoney MJ. Renal tubular dysgenesis, absent nipples, and multiple malformations in three brothers: a new, lethal syndrome. Am J Med Genet. 1998;80:335–342.
doi: 10.1002/(SICI)1096-8628(19981204)80:4<335::AID-AJMG7>3.0.CO;2-#
Horvath GA, Armstrong L. Report of a fourth individual with a lethal syndrome of choanal atresia, athelia, evidence of renal tubulopathy, and family history of neck cysts. Am J Med Genet A. 2007;143A:1231–1235.
doi: 10.1002/ajmg.a.31734
Tompa P, Schad E, Tantos A, Kalmar L. Intrinsically disordered proteins: emerging interaction specialists. Curr Opin Struct Biol. 2015;35:49–59.
doi: 10.1016/j.sbi.2015.08.009
Simoes-Costa M, Bronner ME. Establishing neural crest identity: a gene regulatory recipe. Development. 2015;142:242–257.
doi: 10.1242/dev.105445
Banka S, Sayer R, Breen C, et al. Genotype-phenotype specificity in Menke-Hennekam syndrome caused by missense variants in exon 30 or 31 of CREBBP. Am J Med Genet A. 2019;179:1058–1062.
doi: 10.1002/ajmg.a.61131
Cuvertino S, Stuart HM, Chandler KE. et al. ACTB loss-of-function mutations result in a pleiotropic developmental disorder. Am J Hum Genet. 2017;101:1021–1033.
doi: 10.1016/j.ajhg.2017.11.006

Auteurs

Sara Cuvertino (S)

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, UK.
Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, UK.

Verity Hartill (V)

Leeds Institute of Medical Research, Faculty of Medicine and Health, The University of Leeds, Leeds, UK.
Department of Clinical Genetics, Chapel Allerton Hospital, Leeds Teaching Hospitals Trust, Leeds, UK.

Alice Colyer (A)

Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, The University of Leeds, Leeds, UK.

Terence Garner (T)

Division of Developmental Biology & Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, UK.

Nisha Nair (N)

Centre of Genetics & Genomics Versus Arthritis, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.

Lihadh Al-Gazali (L)

Department of Paediatrics, College of Medicine & Health Sciences, United Arab University, Al-Ain, UAE.

Natalie Canham (N)

Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
North West Thames Regional Genetics Service, Northwick Park Hospital, Harrow, UK.

Victor Faundes (V)

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, UK.
Laboratorio de Genética y Enfermedades Metabólicas, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago, Chile.

Frances Flinter (F)

Department of Clinical Genetics, Guy's & St Thomas NHS Foundation Trust, London, UK.

Jozef Hertecant (J)

Department of Paediatrics, Tawam Hospital, Al-Ain, UAE.

Muriel Holder-Espinasse (M)

Department of Clinical Genetics, Guy's & St Thomas NHS Foundation Trust, London, UK.

Brian Jackson (B)

Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, The University of Leeds, Leeds, UK.

Sally Ann Lynch (SA)

Temple street Children's University Hospital, Dublin, Ireland.

Fatima Nadat (F)

Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, The University of Leeds, Leeds, UK.

Vagheesh M Narasimhan (VM)

Wellcome Trust Sanger Institute, Cambridge, UK.

Michelle Peckham (M)

Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, The University of Leeds, Leeds, UK.

Robert Sellers (R)

Division of Developmental Biology & Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, UK.

Marco Seri (M)

Medical Genetics Unit, St. Orsola-Malpighi, University of Bologna, Bologna, Italy.

Francesca Montanari (F)

Medical Genetics Unit, St. Orsola-Malpighi, University of Bologna, Bologna, Italy.

Laura Southgate (L)

Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
Department of Medical & Molecular Genetics, King's College London, London, UK.

Gabriella Maria Squeo (GM)

Division of Medical Genetics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy.

Richard Trembath (R)

Department of Medical & Molecular Genetics, King's College London, London, UK.

David van Heel (D)

Queen Mary University of London, London, UK.

Santina Venuto (S)

Division of Medical Genetics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy.

Daniel Weisberg (D)

Clinical Psychology Department, Royal Manchester Children's Hospital, Manchester University Foundation NHS Trust, Health Innovation Manchester, Manchester, UK.

Karen Stals (K)

Molecular Genetics Department, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.

Sian Ellard (S)

Molecular Genetics Department, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.

Anne Barton (A)

Centre of Genetics & Genomics Versus Arthritis, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.

Susan J Kimber (SJ)

Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, UK.

Eamonn Sheridan (E)

Leeds Institute of Medical Research, Faculty of Medicine and Health, The University of Leeds, Leeds, UK.
Department of Clinical Genetics, Chapel Allerton Hospital, Leeds Teaching Hospitals Trust, Leeds, UK.

Giuseppe Merla (G)

Division of Medical Genetics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy.

Adam Stevens (A)

Division of Developmental Biology & Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, UK.

Colin A Johnson (CA)

Leeds Institute of Medical Research, Faculty of Medicine and Health, The University of Leeds, Leeds, UK.

Siddharth Banka (S)

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, UK. Siddharth.Banka@manchester.ac.uk.
Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University Foundation NHS Trust, Health Innovation Manchester, Manchester, UK. Siddharth.Banka@manchester.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH